Rallybio RLYB Stock
Rallybio Price Chart
Rallybio RLYB Financial and Trading Overview
| Rallybio stock price | 17.05 USD |
| Previous Close | 16.81 USD |
| Open | 16.61 USD |
| Bid | 11.89 USD x 200 |
| Ask | 21.6 USD x 200 |
| Day's Range | 16.5 - 17.05 USD |
| 52 Week Range | 3.67 - 17.57 USD |
| Volume | 14.14K USD |
| Avg. Volume | 43.68K USD |
| Market Cap | 89.16M USD |
| Beta (5Y Monthly) | -0.857 |
| PE Ratio (TTM) | 2.0728395 |
| EPS (TTM) | 7.99 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RLYB Valuation Measures
| Enterprise Value | -3685721 USD |
| Trailing P/E | 2.0728395 |
| Forward P/E | -3.1092594 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 138.02365 |
| Price/Book (mrq) | 0.94294065 |
| Enterprise Value/Revenue | -5.705 |
| Enterprise Value/EBITDA | 0.145 |
Trading Information
Rallybio Stock Price History
| Beta (5Y Monthly) | -0.857 |
| 52-Week Change | 276.56% |
| S&P500 52-Week Change | 20.20% |
| 52 Week High | 17.57 USD |
| 52 Week Low | 3.67 USD |
| 50-Day Moving Average | 16.27 USD |
| 200-Day Moving Average | 10.47 USD |
RLYB Share Statistics
| Avg. Volume (3 month) | 43.68K USD |
| Avg. Daily Volume (10-Days) | 9.69K USD |
| Shares Outstanding | 5.31M |
| Float | 2.18M |
| Short Ratio | 1.56 |
| % Held by Insiders | 4.20% |
| % Held by Institutions | 229.87% |
| Shares Short | 54.56K |
| Short % of Float | 1.23% |
| Short % of Shares Outstanding | 1.02% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 7051.23% |
| Operating Margin (ttm) | -3935.44% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.31% |
| Return on Equity (ttm) | 64.85% |
Income Statement
| Revenue (ttm) | 646K USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -16542000 USD |
| EBITDA | -25380000 USD |
| Net Income Avi to Common (ttm) | 45.55M USD |
| Diluted EPS (ttm) | 8.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 92.85M USD |
| Total Cash Per Share (mrq) | 17.48 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 27.265 |
| Book Value Per Share (mrq) | 17.806 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 26.71M USD |
| Levered Free Cash Flow (ttm) | -14290375 USD |
Profile of Rallybio
| Country | United States |
| State | CT |
| City | New Haven |
| Address | 234 Church Street |
| ZIP | 06510 |
| Phone | 203 859 3820 |
| Website | https://www.rallybio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.
Q&A For Rallybio Stock
What is a current RLYB stock price?
Rallybio RLYB stock price today per share is 17.05 USD.
How to purchase Rallybio stock?
You can buy RLYB shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rallybio?
The stock symbol or ticker of Rallybio is RLYB.
Which industry does the Rallybio company belong to?
The Rallybio industry is Biotechnology.
How many shares does Rallybio have in circulation?
The max supply of Rallybio shares is 5.31M.
What is Rallybio Price to Earnings Ratio (PE Ratio)?
Rallybio PE Ratio is 2.13391730 now.
What was Rallybio earnings per share over the trailing 12 months (TTM)?
Rallybio EPS is 7.99 USD over the trailing 12 months.
Which sector does the Rallybio company belong to?
The Rallybio sector is Healthcare.
Rallybio RLYB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26127.07 USD — |
-0.92
|
1.37B USD — | 25995.53 USD — | 26130.69 USD — | — - | 1.37B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12830.46 USD — |
-0.94
|
— — | 12766.84 USD — | 12830.46 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7143.69 USD — |
+0.26
|
— — | 7112.22 USD — | 7169.53 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1341.26 USD — |
+0.08
|
— — | 1335.94 USD — | 1346.72 USD — | — - | — — |
- {{ link.label }} {{link}}
